当地时间7月21日,英国生物医药巨头阿斯利康(AZ)宣布,计划到2030年斥资500亿美元扩大在美国的制造和研发能力,预计这项投资将在美国创造数万个就业岗位。关税大棒下的新布局在特朗普关税大棒下,进口药品可能面临巨额关税,阿斯利康似乎在提前做部署。该公司在一份声明中表示,这笔投资将为弗吉尼亚州的一家新药品生产工厂提供资金,并扩大其在马里兰州、马萨诸塞州、加利福尼亚州、印第安纳州和得克萨斯州的研发和...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.